Tesofensine (NS-2330) is an investigational drug acting as a pre-synaptic serotonin–noradrenaline–dopamine reuptake inhibitor and has the potential for the treatment of obesity. Tesofensine was originally developed by a Danish biotechnology company, NeuroSearch, who transferred the rights to Saniona in 2014.

纯度：≥98%

CAS：195875-84-4